Related Experiment Video
Updated: Jul 19, 2025
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
A perspective on the metastasis suppressor field
Imran Khan1, Patricia S Steeg2
1Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Building 37, Room 1126, NCI, NIH, Bethesda, MD, 20892, USA.
Abstract:
Metastasis is the leading cause of cancer patient mortality. Metastasis suppressors are genes that, upon reexpression in metastatic tumor cells to levels observed in their nonmetastatic counterparts, significantly reduce metastasis without affecting the growth of the primary tumor. Analysis of > 30 metastasis suppressors revealed complex mechanisms of action that include multiple signaling pathways, transcriptional patterns, posttranscriptional regulatory mechanisms, and potential contributions of genomic stability. Clinical testing of strategies to re-establish a validated metastasis suppressor pathway in tumors is best directed to the adjuvant setting, with the goal of inhibiting the outgrowth of occult micrometastases.
Insights
Metastasis suppressor genes significantly reduce cancer spread without impacting primary tumor growth. Re-establishing these gene pathways may help prevent cancer recurrence after initial treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastasis is the primary cause of cancer-related deaths.
- Metastasis suppressor genes inhibit cancer cell spread when re-expressed.
- Understanding these genes is crucial for developing new cancer therapies.
Purpose of the Study:
- To analyze the mechanisms of action for over 30 metastasis suppressors.
- To explore strategies for re-establishing metastasis suppressor pathways in tumors.
Main Methods:
- Analysis of over 30 metastasis suppressors.
- Investigating signaling pathways, transcriptional and posttranscriptional regulation, and genomic stability.
Main Results:
- Metastasis suppressors act through complex mechanisms involving multiple cellular processes.
- These genes reduce metastasis without affecting primary tumor growth.
Conclusions:
- Re-expressing metastasis suppressors offers a therapeutic strategy against cancer spread.
- Clinical application should focus on the adjuvant setting to target micrometastases.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation